alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    EXHIBIT 23.2

                REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

Board of Directors and Stockholders
U.S. Bioscience, Inc.

We have audited the consolidated balance sheet of U.S. Bioscience, Inc. as of
December 31, 1998 and the related consolidated statements of operations, cash
flows and stockholders' equity for each of the two years in the period ended
December 31, 1998 (not presented separately herein). These consolidated
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of U.S. Bioscience,
Inc. at December 31, 1998, and the consolidated results of its operations and
its cash flows for each of the two years in the period ended December 31, 1998,
in conformity with accounting principles generally accepted in the United
States.


                                                     /s/ Ernst & Young LLP

Philadelphia, Pennsylvania
February 15, 1999
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANTS FORM 10-K FOR THE YEAR ENDED JUNE 30, 1997 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               JUN-30-1997
<CASH>                                          23,246
<SECURITIES>                                         0
<RECEIVABLES>                                      700
<ALLOWANCES>                                      (30)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                24,231
<PP&E>                                           5,596
<DEPRECIATION>                                   (770)
<TOTAL-ASSETS>                                  29,057
<CURRENT-LIABILITIES>                            4,177
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            75
<OTHER-SE>                                      24,805
<TOTAL-LIABILITY-AND-EQUITY>                    29,057
<SALES>                                              0
<TOTAL-REVENUES>                                 4,835
<CGS>                                                0
<TOTAL-COSTS>                                    3,753
<OTHER-EXPENSES>                                 3,784
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  17
<INCOME-PRETAX>                                    566
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                566
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       566
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .08
        

</TABLE>
<PAGE>





                                                                      Exhibit 23


                        Consent of Independent Auditors


The Board of Directors
Gensis Health Ventures, Inc.:

We consent to incorporation by reference in the registration statement dated
September 12, 1996 on Form S-8 (No. 333-11845) for the 1985 Amended and Restated
Employee Stock Option Plan and the 1992 Stock Option Plan for Non-Employee
Directors of Genesis Health Ventures, Inc., and the registration statement dated
September 12, 1996 on Form S-3 (No. 333-11847) for the registration of common 
shares, of our reports dated November 20, 1996 relating to the consolidated 
balance sheets of Genesis Health Ventures, Inc. and subsidiaries as of 
September 30, 1996 and 1995 and the related consolidated statements of 
operations, shareholders' equity and cash flows for each of the years in the 
three-year period ended September 30, 1996 and the related schedule, which 
reports appear in the September 30, 1996 annual report on Form 10-K of Genesis 
Health Ventures, Inc.


                                                         KPMG Peat Marwick LLP




Philadelphia, Pennsylvania
December 27, 1996
[Federal Register Volume 89, Number 174 (Monday, September 9, 2024)]
[Notices]
[Page 73088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20180]



[[Page 73088]]

-----------------------------------------------------------------------

EXPORT-IMPORT BANK

[Public Notice: 2024-6094]


Agency Information Collection Activities: Submission to the 
Office of Management and Budget for Review and Approval; Comment 
Request; EIB 92-41, Application for Financial Institution Short-Term, 
Single-Buyer Insurance

AGENCY: Export-Import Bank of the United States.

ACTION: Submission for OMB review and comments request.

-----------------------------------------------------------------------

SUMMARY: The Export-Import Banks of the United States (EXIM), as part 
of its continuing effort to reduce paperwork and respondent burden, 
invites the public and other Federal Agencies to comment on the 
proposed information collection, as required by the Paperwork Reduction 
Act of 1995. This collection of information is necessary to determine 
eligibility of the underlying export transaction for EXIM insurance 
coverage.

DATES: Comments must be received on or before November 8, 2024 to be 
assured of consideration.

ADDRESSES: Comments may be submitted electronically on 
www.regulations.gov (EIB 10-02), by email <a href="/cdn-cgi/l/email-protection#f6939281978492d895998686999a97b6938e9f9bd8919980"><span class="__cf_email__" data-cfemail="751011021407115b161a05051a191435100d1c185b121a03">[email protected]</span></a>; or 
by mail to Edward Coppola, Export-Import Bank of the United States, 811 
Vermont Ave. NW, Washington, DC. The application tool can be reviewed 
at: https://img.exim.gov/s3fs-public/pub/pending/FIBC_Application_eib92-41_2024_FINAL_508.pdf.

FOR FURTHER INFORMATION CONTACT: To request additional information, 
please contact Edward Coppola, <a href="/cdn-cgi/l/email-protection#bdd8d9cadccfd993ded2cdcdd2d1dcfdd8c5d4d093dad2cb"><span class="__cf_email__" data-cfemail="690c0d1e081b0d470a061919060508290c110004470e061f">[email protected]</span></a>; 202-565-3717.

SUPPLEMENTARY INFORMATION: 
    Title and Form Number: EIB 92-41, Application for Financial 
Institution Short-Term, Single-Buyer Insurance.
    OMB Number: 3048-0019.
    Type of Review: Regular.
    Need and Use: The Application for Financial Institution Short-term 
Single-Buyer Insurance form will be used by financial institution 
applicants to provide EXIM with the information necessary to determine 
if the subject transaction is eligible for EXIM insurance coverage.
    Affected Public: This form affects entities involved in the export 
of U.S. goods and services.
    Annual Number of Respondents: 215.
    Estimated Time per Respondent: 1.6 hours.
    Annual Burden Hours: 344.
    Frequency of Reporting of Use: Annual.

Andrew Smith,
Records Officer.
[FR Doc. 2024-20180 Filed 9-6-24; 8:45 am]
BILLING CODE 6690-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit        32.1**

 

Certification by Jeffrey Siegel, Chief Executive Officer and President, and        Laurence Winoker, Senior Vice President – Finance, Treasurer and Chief Financial        Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the        Sarbanes-Oxley Act of 2002.

 

I,        Jeffrey Siegel, Chief Executive Officer and President, and I, Laurence Winoker, Senior Vice        President – Finance, Treasurer and Chief Financial Officer, of Lifetime Brands, Inc.,        a Delaware corporation (the “Company”), each hereby certifies that:

 

|   | (1) | The Company’s Annual report on Form 10-K for the year                        ended December 31, 2007 (the “Form 10-K”) fully complies with                        the requirements of Section 13(a) or 15(d) of the Securities Exchange Act                        of 1934, as amended; and |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

         

|   | (2) | information contained in the Form 10-K fairly presents, in                        all material respects, the financial condition and results of operations of                        the Company. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

         

 

| /s/ Jeffrey SiegelJeffrey SiegelChief Executive Officer and President | /s/ Laurence WinokerLaurence WinokerSenior Vice President- Finance, Treasurerand Chief Financial Officer |
|-----------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
|  

Date: March 14, 2008                                          |  

Date: March 14, 2008                                                                             |

 

 

A signed        original of this written statement required by Section 1350 has been provided to Lifetime        Brands, Inc. and will be retained by Lifetime Brands, Inc. and furnished to the Securities        and Exchange Commission or its staff, upon request.
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER>  1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-END>                               SEP-30-1997
<CASH>                                       2,028
<INT-BEARING-DEPOSITS>                         355
<FED-FUNDS-SOLD>                                 0
<TRADING-ASSETS>                                 0
<INVESTMENTS-HELD-FOR-SALE>                  7,600
<INVESTMENTS-CARRYING>                         633
<INVESTMENTS-MARKET>                           633
<LOANS>                                     45,779
<ALLOWANCE>                                    365
<TOTAL-ASSETS>                              59,580
<DEPOSITS>                                  43,101
<SHORT-TERM>                                 6,998
<LIABILITIES-OTHER>                            774
<LONG-TERM>                                  1,766
<COMMON>                                         5
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<OTHER-SE>                                   6,936
<TOTAL-LIABILITIES-AND-EQUITY>               6,941
<INTEREST-LOAN>                                929
<INTEREST-INVEST>                              139
<INTEREST-OTHER>                                 0
<INTEREST-TOTAL>                             1,068
<INTEREST-DEPOSIT>                             519
<INTEREST-EXPENSE>                             648
<INTEREST-INCOME-NET>                          420
<LOAN-LOSSES>                                   16
<SECURITIES-GAINS>                             212
<EXPENSE-OTHER>                                507
<INCOME-PRETAX>                                188
<INCOME-PRE-EXTRAORDINARY>                     188
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                   121
<EPS-PRIMARY>                                 0.26
<EPS-DILUTED>                                 0.26
<YIELD-ACTUAL>                                3.13
<LOANS-NON>                                    268
<LOANS-PAST>                                     0
<LOANS-TROUBLED>                                 0
<LOANS-PROBLEM>                                  0
<ALLOWANCE-OPEN>                               351
<CHARGE-OFFS>                                    2
<RECOVERIES>                                     0
<ALLOWANCE-CLOSE>                              365
<ALLOWANCE-DOMESTIC>                           340
<ALLOWANCE-FOREIGN>                              0
<ALLOWANCE-UNALLOCATED>                         25
        

</TABLE>
##### 



COMMON STOCK            COMMON STOCK
NUMBER SHARES
SFU-
GENELABS
INCORPORATED UNDER THE LAWS OF            TECHNOLOGIES CUSIP 368706 20 6
THE STATE OF CALIFORNIA
SEE REVERSE FOR CERTAIN DEFINITIONS
THIS CERTIFIES THAT
SPECIMEN
is the owner of
FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF
GENELABS TECHNOLOGIES, INC.
transferable on the books of the Corporation by the holder hereof in person or by duly authorized
attorney upon the surrender of this certificate properly endorsed. This certificate is not valid
until countersigned by the Transfer Agent and registered b y the Registrar.
WITNESS the facsimile seal of the Corporation and the facsimile signatures of its duly authorized
officers.
Dated:
Secretary President and Chief Executive Officer
COUNTERSIGNED AND REFISTERED
MELLON INVESTOR SERVICES LLC
TRANSFER AGENT AND REGISTRAR
AUTHORIZED SIGNATURE
GENELABS TECHNOLOGIES, INC. CALIFORNIA
CORPORATE SEAL OCTOBER 23
1985




---



##### 



GENELABS TECHNOLOGIES, INC.
 
  TEN COM-
    
    as tenants in common
    
    
    
    UNIF GIFT MIN ACT -
    
    
    
    CustodianTEN ENT-
    
    as tenants by the entireties
    
    
    
    
    
    (Cust)
    
    
    
    (Minor)JT TEN-
    
    as joint tenants with right
    
    
    
    
    
    under uniform gifts to minorsof survivorship and not  as
tenants in common
    
    
    
    
    
    Act(State)
 UNIF TRF MIN ACT -
    
    
    
    Custodian
    
    (until age)(Cust)under Uniform Transfers(Minor)to Minors Act(State)
  For Value received,
    
    
    
    hereby sell, assign and transfer unto
 
  
 
   
  
 
 Shares
  Attorney
  Dated
    
    
    
    
    
    XX
NOTICE:
    
    THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME(S)
AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR
WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER
  ByTHE SIGNATURE(S) MUST BE GUARANTEED
BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANK, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS
AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE
GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.
#### WALL v. GILLEN.

No. 7590.

Court of Civil Appeals of Texas. Austin.

Sept. 27, 1933.

W. H. Browning, of Lampasas, for appellant.

J. J. Byrne, of Lampasas, for appellee.

PER CURIAM.

Motion for rehearing of a motion to require the clerk tó file the record; and to set aside an order affirming on certificate.

The judgment was rendered February 15, 1933. The last day for filing record in this court was April 16, 1933. Chapter 67, p. 142, Gen. Laws, 43d Leg. (1933), amending R. C. S. art. 1839 (Vernon’s Ann. Civ. St. art. 1839), which became effective April 14, 1933, provides that: “3⁄8 3⁄8 * By motion filed before, at, or within a reasonable time, not exceeding fifteen days, after the expiration of such sixty day period, showing good cause to have existed within such sixty day period, why said transcript could not be so filed, the Court of Civil Appeals may permit the same to be thereafter filed upon such terms as it shall prescribe.” ■

No motion was filed in this court to extend the time or permit the filing of the record until July. 11, 1933.

In the recent case of Hunter v. Moore, 62 S.W(2d) 97, 100 (opinion of Commission adopted by Supreme Court), it was held that, where the motion was not filed within the sixty-day period, the Court of Civil Appeals was without power to extend the time, “even though good cause existed for failing to file within the time required by law.” This decision denies to the Court of Civil Appeals any discretion, when the motion is not so filed.

The only change made by chapter 67 (above) is to extend the time within which the motion may be filed fifteen, days beyond the sixty-day period. The chapter expressly requires the motion to be filed within the time specified. This language is, if anything, even more pointed than that of the 1931 amendment of the article (chapter 66, p. 100, Gen. Laws Reg. Sess., 42d Leg.), construed in Hunter v. Moore, above.

One other circumstance might be adverted to, if need be, in arriving at the legislative intent as expressed in the proviso of chapter 67. The original bill as introduced in the Legislature (S. B. 57) was a judicial council measure (Bill No. 7, p. 21, 4th Annual Report Tex. Civ. Jud. G.), the proviso in which read: “ * * * Provided that for good cause shown the court shall permit the transcript to be thereafter filed upon such terms as it shall prescribe.”

The amendment of this proviso evidences a deliberate legislative purpose to withhold from the Courts of Civil Appeals any discretion whatever to entertain a motion filed after the stated period.

This viety renders immaterial whether a good excuse for not filing the record within the statutory period is shown.

The motion is overruled.

Overruled.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Substance Abuse and Mental Health Services Administration (SAMHSA) 

Pursuant to Public Law 92-463, notice is hereby given of the following meetings of SAMHSA Special Emphasis Panels I in December 2000. 

A summary of the meetings and a roster of the members may be obtained from: Ms. Coral Sweeney, Review Specialist, SAMHSA, Office of Policy and Program Coordination, Division of Extramural Activities, Policy, and Review, 5600 Fishers Lane, Room 17-89, Rockville, Maryland 20857. Telephone: 301-443-2998. 

Substantive program information may be obtained from the individual named as Contact for the meeting listed below. 

                    The meetings will include the review, discussion and evaluation of individual grant applications. These discussions could reveal personal information concerning individuals associated with the applications. Accordingly, these meetings are concerned with matters exempt from mandatory disclosure in Title 5 U.S.C. 552b                    ©                     (6) and 5 U.S.C. App.2, § 10(d).                

*Committee Name:*                         SAMHSA Special Emphasis Panel I (SEP I).                     

*Meeting Date:*                         December 11-15, 2000.                     

*Place:*                         Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                     

*Closed:*                         December 11, 2000 to Adjournment.                     

*Panel:*                         Community Action Grants, PA 00-003 2 Committees.                     

*Contact:*                         Diane McMenamin, Director, Division of Extramural Activities, Policy and Review, Parklawn Building, 5600 Fishers Lane, Room 1789, Rockville, Maryland 20857.                     

This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the review and funding cycle.

Dated: November 27, 2000. 

Coral Sweeney, 

Review Specialist, Substance Abuse and Mental Health Services Administration. 

[FR Doc. 00-31409 Filed 12-8-00; 8:45 am] 

BILLING CODE 4162-20-U